市場調查報告書
商品編碼
1359584
羧基療法市場規模-按產品類型(台式、攜帶式)、按應用(美容醫學、婦科、血管學、骨科和風濕病、運動醫學)、按最終用途(醫院、美容診所、MedSpa)-2023年全球預測- 2032Carboxy Therapy Market Size-By Product Type (Table Top, Portable), By Application (Aesthetic Medicine, Gynecology, Angiology, Orthopaedics and Rheumatology, Sports Medicine), By End-use (Hospitals, Aesthetic Clinics, MedSpa)-Global Forecast 2023-2032 |
在全球美學和外觀增強意識不斷增強的推動下,羧基療法市場規模預計從 2023 年到 2032 年複合年成長率將達到 12.2%。近年來,在社群媒體和視覺文化的持續發展趨勢中,人們越來越注重自己的外表,並尋求非侵入性治療來增強自己的美麗。這增加了對羧基療法的需求,進一步為皮膚再生和身體輪廓提供多功能解決方案,以滿足對微創美容手術不斷成長的需求。對美學和自我形象的日益關注預計也將影響行業的成長。
整個羧基治療市場分為產品類型、應用、最終用途和地區。
根據產品類型,攜帶式細分市場的行業價值預計將在 2023 年至 2032 年期間獲得成長。攜帶式羧基治療設備提供便利性和多功能性,使治療能夠在各種臨床環境、水療中心和家庭中進行。此外,這些設備的緊湊性和方便用戶使用性使其在醫生和患者中廣受歡迎,因為它們易於使用和移動。嫩膚、減少脂肪團和疤痕治療方面的成本效益優勢,為更廣泛的受眾提供可及性,也將有助於該細分市場的成長。
婦科應用領域的羧基治療市場預計到 2032 年將產生可觀的收入。這種成長可歸因於針對各種婦科疾病的非侵入性有效治療方法的廣泛普及。根據 NCBI 2023 年 8 月發布的一項研究,估計全球有超過 4.23 億 20 歲及以上的人患有尿失禁。此外,陰道鬆弛和性功能障礙的盛行率不斷上升,促使女性採用羧基療法作為改善私密健康的非手術選擇,進一步影響了該細分市場的成長。
預計到2032年,亞太地區羧基治療市場規模將出現強勁成長。這歸因於中產階級人口的不斷擴大、可支配收入的增加、對非侵入性美容治療意識的不斷提高以及對年輕和健康外觀的日益成長的渴望肌膚。此外,韓國和泰國等醫療旅遊目的地已經普及了該手術,吸引了來自世界各地的患者,從而支持了該行業的成長。
Carboxy Therapy Market size is projected to witness 12.2% CAGR from 2023 to 2032, driven by the increasing awareness of aesthetics and appearance enhancement worldwide. In recent years, individuals have grown increasingly conscious of their appearance and are seeking non-invasive treatments to enhance their beauty amidst the ongoing trends of social media and visual culture. This has surged the demand for carboxy therapy, further offering versatile solutions for skin rejuvenation and body contouring to match the rising demand for minimally invasive aesthetic procedures. The growing focus on aesthetics and self-image is also expected to influence the industry growth.
The overall carboxy therapy market is segmented into product type, application, end-use, and region.
Based on product type, the industry value from the portable segment is poised to gain traction from 2023 to 2032. Portable carboxy therapy devices offer convenience and versatility, enabling treatments to be performed in various clinical settings, spas, and at home. Moreover, the compact and user-friendly nature of these devices has surged their popularity among practitioners and patients to offer ease of use and mobility. Advantages of cost-effectiveness in skin rejuvenation, cellulite reduction, and scar therapy to render accessibility to broader audience will also contribute to the segment growth.
Carboxy therapy market from the gynecology application segment is expected to generate considerable revenue by 2032. The growth can be attributed to the significant popularity of non-invasive and effective treatment methods for various gynecological conditions. According to a study published by NCBI in August 2023, it is estimated that over 423 million persons aged 20 years and older globally suffer from urine incontinence. In addition, the rising prevalence of vaginal laxity, and sexual dysfunction is surging the adoption of carboxy therapy among women as non-surgical option for improving intimate health, further influencing the segment growth.
Asia Pacific carboxy therapy market size is expected to witness robust growth through 2032. This is attributed to the expanding middle-class population with increased disposable incomes, the rising awareness of non-invasive aesthetic treatments, and the growing desire for youthful and healthy-looking skin. Moreover, medical tourism destinations, such as South Korea and Thailand have popularized the procedure, attracting patients from around the world, in turn, supporting the industry growth.